These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34277913)

  • 21. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
    Lee HY; Tey HL; Pang SM; Thirumoorthy T
    Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Epidemiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis during 2010-2015 at Shahid Faghihi Hospital, Shiraz, Iran.
    Talebi R; Saki N; Raeisi Shahraki H; Owji SH
    Iran J Med Sci; 2018 Jul; 43(4):421-425. PubMed ID: 30046212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
    Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
    Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea.
    Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):690-695.e2. PubMed ID: 31614216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
    Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
    Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
    Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
    Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
    Çekiç Ş; Canıtez Y; Sapan N
    Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.
    Lee HY; Dunant A; Sekula P; Mockenhaupt M; Wolkenstein P; Valeyrie-Allanore L; Naldi L; Halevy S; Roujeau JC
    Br J Dermatol; 2012 Sep; 167(3):555-62. PubMed ID: 22639874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine.
    Huang HT; Chang CL; Tzeng DS
    Asian J Psychiatr; 2010 Dec; 3(4):240-2. PubMed ID: 23050897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stevens-Johnson syndrome induced by a combination of lamotrigine and valproic acid.
    Kavitha S; Anbuchelvan T; Mahalakshmi V; Sathya R; Sabarinath TR; Gururaj N; Kalaivani S
    J Pharm Bioallied Sci; 2015 Aug; 7(Suppl 2):S756-8. PubMed ID: 26538961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gilbert M; Scherrer LA
    Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.
    Schöpf E; Stühmer A; Rzany B; Victor N; Zentgraf R; Kapp JF
    Arch Dermatol; 1991 Jun; 127(6):839-42. PubMed ID: 2036029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cheng L
    Front Pharmacol; 2021; 12():588063. PubMed ID: 33981213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child.
    Yapici AK; Fidanci MK; Kilic S; Balamtekin N; Mutluay Arslan M; Yavuz ST; Kalman S
    Ann Burns Fire Disasters; 2014 Sep; 27(3):121-5. PubMed ID: 26170788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.